skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Global Generics & Biosimilars Awards 2020

Our expert judges have assessed all the entries for the Global Generics & Biosimilars Digital Awards 2020 to create the shortlist of Award finalists.

We are delighted to announce the shortlist for the Global Generics & Biosimilars Awards.

Over the past month, our panel of 17 industry expert judges has reviewed all the entries to produce a shortlist that demonstrates the wealth of innovation, dedication and hard work that the Generics, Biosimilars and Value Added Medicines industries have shown over the past year.

The full range of industry activities is represented: from acquisitions and regulatory achievements, to legal strategies, value added medicines initiatives and CSR breakthroughs. The Global Generics & Biosimilars Awards provides the industry with an opportunity to acknowledge its highest achievers across all parts of the industries, and to recognise both corporate and individual achievements.

Winners of the categories will receive their Awards during an online event on November, 3.

Online Registration is now open, so make sure you request your complimentary ticket today.  

Congratulations to all our finalists and good luck on the night!

Company of the Year
Accord Healthcare
Samsung Bioepis 

Company of the Year, Americas
Coherus BioSciences

Company of the Year, Asia-Pacific
Beximco Pharma
Macleods pharmaceuticals 
Piramal Pharma Solutions 
Samsung Bioepis 

Company of the Year, EMEA
Accord Healthcare

Acquisition of the Year
Sandoz - Acquisition of Aspen’s Japanese operations
Towa Pharmaceutical – Acquisition of Esteve’s generics division, Pensa Investments
Zentiva - Acquisition of Sanofi’s manufacturing site in Ankleshwar, India
Zentiva - Acquisition of Alvogen’s CEE business

API Supplier of the Year 
Dr. Reddy's Laboratories
Piramal Pharma Solutions
R L Fine Chem

Biosimilar Initiative of the Year
Accord Healthcare - Pelgraz Pre-Filled Injector
Alvotech - Alvotech and Teva strategic partnership to collaborate in the US biosimilars market  
Samsung Bioepsis - has approved and marketed four biosimilars which have treated more than 215,000 patients in Europe
Sandoz – Sandoz Biopharmaceuticals reached a deal with Polpharma Biologics to commercialize natalizumab
Shanghai Henlius Biotech - Zercepac trastuzumab biosimilar
Stada & Alvotech - Stada alliances with Alvotech and Bausch + Lomb

Business Development of the Year
Accord Healthcare – Accord has rapidly become one of the leading suppliers of chemotherapy and adjunctive treatments in Europe
Alvogen – Alvogen and Alvotech have introduced a new corporate identity for its B2B operations called Adalvo
Hetero Drugs – has been in the forefront of developing, manufacturing, and distributing COVID-19 experimental drugs
Samsung Bioepis -  has set new milestones to prove its leadership in the biosimilars industry
Sandoz – in a joint venture with the Austrian government Sandoz plans to invest more than €150m in its Kundl antibiotics production center 
Stada – struck a comprehensive deal with Alvotech, ensuring its pipeline covers major molecules in the autoimmune, ophthalmic and oncology indications

Corporate Social Responsibility (CSR) Initiative of the Year
Accord Healthcare - Increasing patient access to life-changing medicines through targeted initiatives
Dr. Reddy's Laboratories - Community Health Intervention Program (Chip)
Eurofarma - Private human milk bank, Humanitarian Aid Donations & response initiatives to Covid-19 crisis
Hemofarm Foundation - Programs of Hemofarm Foundation
Sandoz - Covid-19 Pricing Commitment
Stada – Response to Covid-19 crisis 

Industry Partner of the Year 
Lambda Therapeutics Research
Pinsent Masons
Piramal Pharma Solutions
West Pharmaceutical Services

Leader of the Year
Accord Healthcare - Binish Chudgar
mAbxience - Emmanuelle Lepine
PharmEvo - Muhammad Nadeem Rehmat
Sandoz - Richard Saynor
Stada - Peter Goldschmidt 

Legal Strategy of the Year
Alvogen – Defeated two patents protecting Persion's Zohydro ER hydrocodone extended-release capsules until July 2033
Insud Pharma - raising the attention of the Competition Authorities towards vexatious litigation in Europe and the effects these abusive practices have in the generics sector.
Mylan - achieves key milestone to provide US multiple sclerosis patients with more affordable generic version of Biogen's Tecfidera capsules
Mylan - Mylan Invalidates Sanofi's Lantus SoloSTAR Device Patents in IPR Proceedings & Wins District Court Decision Against Sanofi's Lantus SoloSTAR Patent

Regulatory Achievement of the Year
Accord Healthcare - Hydroxychloroquine Tablets
Alvogen - Qsymia (phentermine and topiramate extended-release)
Hetero Europe - Imatinib 600mg tablet
Macleods Pharmaceuticals - Rifapentine 300mg + Isoniazid 300mg
Rosemont Pharmaceuticals - Omeprazole Powder for Oral Suspension
Sandoz - Nitrosamines collaboration project

Value Added Medicine Initiative of the Year
Arven Pharmaceuticals - Cyplos Arvohaler, Salmaterol, Fluticasone propionate
Hetero Europe - Imatinib 600mg tablet
Macleods Pharmaceuticals - Rifapentine 300mg + Isoniazid 300mg
Rosemont Pharmaceuticals - Omeprazole Powder for Oral Suspension

Don't forget to register your online place to watch the online ceremony, request your complimentary place today.

Contact us today

For 2020 Sponsorship Opportunities contact:

Christopher Keeling
Tel: +44 (0) 7917 647 859

For all other enquiries:
Jo Kirkpatrick
Tel: +44 (0) 7917 555 986